CD274 and neoplasm: The subsequently released aPDL1 antibody from the expanded gel matrix blocks the immune‐inhibitory PD‐L1 molecule on the tumor cell surface, thus sensitizing the tumor to antitumor T‐cell immunity (Figure 1).